Gastroenteropancreatic neuroendocrine tumors: Clinical characteristics, diagnosis and prognosis at Hospital Universitario Clinico San Carlos (Madrid)

被引：0

作者：

Paz de Miguel Novoa, Maria ^{[1
]}

Capel, Francisco Fernandez ^{[1
]}

Redondo Sedano, Jesus Vicente ^{[1
]}

Sellers Carrera, Margarita ^{[1
]}

Aranda Jimenez, Veronica ^{[1
]}

Ortiz Pereira, Paloma ^{[1
]}

Sastre Valera, Javier ^{[1
]}

Ortega Medina, Luis ^{[1
]}

Diaz Perez, Jose Angel ^{[1
]}

机构：

[1] Hosp Clin San Carlos, Serv Endocrinol Metab & Nutr, Madrid, Spain

来源：

ENDOCRINOLOGIA Y NUTRICION | 2014年 / 61卷 / 05期

关键词：

Gastrointestinal; Pancreatic; Survival; Neuroendocrine tumors; Treatment;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: Neuroendocrine tumors are a group of neoplasms arising from the neural crest and endoderm and very heterogeneous as regards localization, clinical behavior, aggressiveness, and prognosis. Pancreas and gastrointestinal tract are the most common sites where neuroendocrine tumors can be found. Material and methods: A review was made of all cases of neuroendocrine tumors diagnosed at Hospital Universitario Clinico San Carlos (HUCSC) from January 2007 to May 2012. Data were compared to the results provided by the Registry of the Spanish Group on Neuroendocrine Tumors (RGETNE). Results: The study cohort comprised 78 patients. Gastroenteric nonfunctional tumors were the most common neoplasms. Metastases were found at diagnosis in 50.6% of patients, with nodal involvement being most prevalent. Tumors located in the rectum were associated to the highestrate of metastasis. Overall 2-year survival rate was 74.8% and was related to sex, Ki-67 expression, and presence of metastasis. (C) 2013 SEEN. Published by Elsevier Espana, S.L. All rights reserved.

引用

页码：234 / 241

页数：8

共 9 条

[1] [Anonymous], 2010, WHO Classification of tumors of the digestive system
[2] Capdevilla J, 2010, GUIA PRACTICA DIAGNO
[3] Caplin M, 2011, HDB GASTROENTEROPANC
[4] Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)
Garcia-Carbonero, R.
Capdevila, J.
Crespo-Herrero, G.
Diaz-Perez, J. A.
Martinez del Prado, M. P.
Alonso Orduna, V.
Sevilla-Garcia, I.
Villabona-Artero, C.
Beguiristain-Gomez, A.
Llanos-Munoz, M.
Marazuela, M.
Alvarez-Escola, C.
Castellano, D.
Vilar, E.
Jimenez-Fonseca, P.
Teule, A.
Sastre-Valera, J.
Benavent-Vinuelas, M.
Monleon, A.
Salazar, R.
[J]. ANNALS OF ONCOLOGY, 2010, 21 (09) : 1794 - 1803
[5] Goldfinger S., Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors
[6] Goldfinger SE, CLIN CHARACTERISTICS
[7] Medrano-Guzmán R, 2011, CIR CIR, V79, P459
[8] Oberg K, 2011, ADV NEUROENDOCRINE T
[9] Öberg K, 2012, CLINICS, V67, P109

← 1 →